Although CD155 has been reported to regulate tumor progression through several oncogenic pathways, including the AKT/mTOR and MEK/ERK pathways in specific cancer types such as cervical and colorectal cancers,18,32 our findings suggest that CD155 may also function through non-canonical and context-dependent signaling mechanisms. The gene discussed is MTOR; the disease is cancer.